Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Ganglion Cells | 15 | 2024 | 118 | 5.080 |
Why?
|
| Intraocular Pressure | 17 | 2023 | 128 | 4.800 |
Why?
|
| Glaucoma | 9 | 2022 | 79 | 3.640 |
Why?
|
| Ocular Hypertension | 5 | 2023 | 24 | 2.200 |
Why?
|
| Retinal Degeneration | 4 | 2024 | 103 | 1.500 |
Why?
|
| Color Vision | 3 | 2020 | 11 | 1.340 |
Why?
|
| Retina | 9 | 2024 | 490 | 1.020 |
Why?
|
| Nerve Degeneration | 2 | 2018 | 129 | 0.940 |
Why?
|
| Optic Nerve Diseases | 2 | 2018 | 85 | 0.910 |
Why?
|
| Intracranial Hypertension | 2 | 2018 | 133 | 0.900 |
Why?
|
| Disease Models, Animal | 10 | 2020 | 4685 | 0.860 |
Why?
|
| Ophthalmologists | 1 | 2023 | 14 | 0.830 |
Why?
|
| Virtual Reality | 1 | 2023 | 34 | 0.820 |
Why?
|
| Contrast Sensitivity | 3 | 2020 | 42 | 0.820 |
Why?
|
| Glaucoma, Open-Angle | 4 | 2021 | 36 | 0.810 |
Why?
|
| Color Perception | 1 | 2022 | 12 | 0.740 |
Why?
|
| Dark Adaptation | 3 | 2016 | 36 | 0.710 |
Why?
|
| Amacrine Cells | 2 | 2020 | 43 | 0.690 |
Why?
|
| Adaptation, Ocular | 1 | 2020 | 18 | 0.680 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 107 | 0.670 |
Why?
|
| Light | 2 | 2020 | 183 | 0.660 |
Why?
|
| Capillaries | 1 | 2020 | 71 | 0.660 |
Why?
|
| Retinal Vessels | 1 | 2020 | 78 | 0.640 |
Why?
|
| Regional Blood Flow | 1 | 2020 | 212 | 0.640 |
Why?
|
| Neuroprotective Agents | 2 | 2019 | 161 | 0.630 |
Why?
|
| Diabetic Retinopathy | 4 | 2024 | 168 | 0.600 |
Why?
|
| Trabeculectomy | 2 | 2020 | 15 | 0.550 |
Why?
|
| Vision, Ocular | 1 | 2019 | 131 | 0.550 |
Why?
|
| Neuroprotection | 1 | 2018 | 31 | 0.540 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 101 | 0.540 |
Why?
|
| Drosophila Proteins | 7 | 2008 | 777 | 0.530 |
Why?
|
| Mice, Inbred C57BL | 8 | 2020 | 4754 | 0.510 |
Why?
|
| Optic Nerve | 1 | 2018 | 114 | 0.510 |
Why?
|
| Action Potentials | 2 | 2019 | 494 | 0.510 |
Why?
|
| Photoreceptor Cells, Invertebrate | 5 | 2008 | 59 | 0.500 |
Why?
|
| Tonometry, Ocular | 5 | 2022 | 23 | 0.490 |
Why?
|
| Tomography, Optical Coherence | 6 | 2024 | 490 | 0.490 |
Why?
|
| Nerve Fibers | 4 | 2024 | 76 | 0.490 |
Why?
|
| Nuclear Proteins | 6 | 2008 | 1280 | 0.480 |
Why?
|
| Medical Staff, Hospital | 1 | 2016 | 98 | 0.480 |
Why?
|
| ErbB Receptors | 3 | 2007 | 292 | 0.480 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2015 | 11 | 0.470 |
Why?
|
| Paraproteinemias | 1 | 2015 | 22 | 0.460 |
Why?
|
| Cell Count | 4 | 2016 | 233 | 0.440 |
Why?
|
| Animals | 24 | 2020 | 34798 | 0.430 |
Why?
|
| Filtering Surgery | 1 | 2013 | 4 | 0.410 |
Why?
|
| Silver | 1 | 2013 | 29 | 0.410 |
Why?
|
| Transcription Factors | 6 | 2008 | 2493 | 0.400 |
Why?
|
| Mice | 12 | 2020 | 18466 | 0.400 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2013 | 67 | 0.390 |
Why?
|
| Metal Nanoparticles | 1 | 2013 | 57 | 0.390 |
Why?
|
| Eye Diseases | 2 | 2025 | 117 | 0.390 |
Why?
|
| Drosophila melanogaster | 5 | 2006 | 844 | 0.380 |
Why?
|
| Transcriptome | 1 | 2019 | 1123 | 0.370 |
Why?
|
| Electroretinography | 3 | 2018 | 121 | 0.340 |
Why?
|
| Retinal Diseases | 1 | 2013 | 179 | 0.330 |
Why?
|
| Night Vision | 2 | 2020 | 6 | 0.280 |
Why?
|
| Female | 20 | 2024 | 70695 | 0.280 |
Why?
|
| Ectropion | 1 | 2007 | 5 | 0.280 |
Why?
|
| Eye | 4 | 2006 | 235 | 0.280 |
Why?
|
| Quinazolines | 1 | 2007 | 176 | 0.250 |
Why?
|
| Internship and Residency | 1 | 2016 | 1247 | 0.240 |
Why?
|
| Cell Differentiation | 6 | 2006 | 1960 | 0.240 |
Why?
|
| Cell Survival | 2 | 2020 | 866 | 0.240 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2008 | 257 | 0.230 |
Why?
|
| Skin | 1 | 2007 | 527 | 0.220 |
Why?
|
| Drosophila | 3 | 2008 | 823 | 0.220 |
Why?
|
| Pupa | 1 | 2004 | 23 | 0.220 |
Why?
|
| Vision Disorders | 2 | 2017 | 216 | 0.210 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2014 | 101 | 0.210 |
Why?
|
| Cell Cycle Proteins | 3 | 2008 | 684 | 0.210 |
Why?
|
| Axial Length, Eye | 2 | 2014 | 36 | 0.210 |
Why?
|
| Weightlessness | 1 | 2025 | 77 | 0.210 |
Why?
|
| Papilledema | 1 | 2025 | 83 | 0.210 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 923 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 605 | 0.200 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 1977 | 0.190 |
Why?
|
| Male | 14 | 2024 | 64967 | 0.190 |
Why?
|
| Color | 1 | 2022 | 34 | 0.180 |
Why?
|
| Acceleration | 1 | 2022 | 27 | 0.180 |
Why?
|
| Macula Lutea | 1 | 2022 | 47 | 0.180 |
Why?
|
| Biomarkers | 3 | 2019 | 3407 | 0.180 |
Why?
|
| Physician's Role | 1 | 2023 | 169 | 0.180 |
Why?
|
| Peripheral Nervous System | 1 | 2002 | 44 | 0.180 |
Why?
|
| Space Flight | 1 | 2025 | 165 | 0.180 |
Why?
|
| Insect Proteins | 1 | 2001 | 111 | 0.180 |
Why?
|
| Cell Nucleus | 1 | 2004 | 587 | 0.170 |
Why?
|
| Puromycin | 1 | 2020 | 12 | 0.170 |
Why?
|
| Neuronal Outgrowth | 1 | 2020 | 5 | 0.170 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2020 | 7 | 0.170 |
Why?
|
| Corneal Edema | 1 | 2020 | 11 | 0.170 |
Why?
|
| beta-Alanine | 1 | 2020 | 7 | 0.170 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2020 | 90 | 0.170 |
Why?
|
| Ophthalmology | 1 | 2023 | 200 | 0.170 |
Why?
|
| Pseudotumor Cerebri | 1 | 2022 | 66 | 0.170 |
Why?
|
| Benzoates | 1 | 2020 | 22 | 0.170 |
Why?
|
| rho-Associated Kinases | 1 | 2020 | 51 | 0.160 |
Why?
|
| Electrophysiology | 1 | 2020 | 269 | 0.160 |
Why?
|
| Humans | 23 | 2025 | 132089 | 0.160 |
Why?
|
| Photic Stimulation | 1 | 2020 | 228 | 0.160 |
Why?
|
| Epithelium, Corneal | 1 | 2020 | 171 | 0.150 |
Why?
|
| Suppression, Genetic | 2 | 1995 | 42 | 0.140 |
Why?
|
| Gout | 1 | 2021 | 167 | 0.140 |
Why?
|
| Veterans | 2 | 2021 | 1763 | 0.140 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1826 | 0.140 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 276 | 0.140 |
Why?
|
| Aqueous Humor | 1 | 2017 | 28 | 0.140 |
Why?
|
| Microscopy, Electron | 1 | 2018 | 337 | 0.130 |
Why?
|
| Antihypertensive Agents | 2 | 2023 | 429 | 0.130 |
Why?
|
| Meningeal Carcinomatosis | 1 | 2017 | 5 | 0.130 |
Why?
|
| Cancer Care Facilities | 1 | 2017 | 36 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1672 | 0.130 |
Why?
|
| Repressor Proteins | 1 | 2001 | 812 | 0.130 |
Why?
|
| Cell Death | 2 | 2017 | 241 | 0.130 |
Why?
|
| Genes, src | 2 | 1995 | 3 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 408 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 279 | 0.120 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 257 | 0.120 |
Why?
|
| Thymus Hormones | 1 | 1995 | 2 | 0.120 |
Why?
|
| Photophobia | 1 | 2015 | 9 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2018 | 876 | 0.120 |
Why?
|
| Tubulin | 1 | 2015 | 72 | 0.110 |
Why?
|
| Retinal Neurons | 1 | 2015 | 13 | 0.110 |
Why?
|
| Sensory Thresholds | 1 | 2014 | 34 | 0.110 |
Why?
|
| Cells, Cultured | 1 | 2020 | 3037 | 0.110 |
Why?
|
| Ribonucleoproteins | 1 | 1995 | 62 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2004 | 4704 | 0.110 |
Why?
|
| Hospitals, Veterans | 1 | 2016 | 346 | 0.110 |
Why?
|
| Visual Fields | 1 | 2015 | 144 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 363 | 0.100 |
Why?
|
| Intracranial Pressure | 1 | 2015 | 212 | 0.100 |
Why?
|
| Middle Aged | 8 | 2024 | 28998 | 0.100 |
Why?
|
| Aged | 9 | 2024 | 21438 | 0.100 |
Why?
|
| Blister | 1 | 2013 | 22 | 0.100 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2017 | 691 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 1132 | 0.100 |
Why?
|
| Mitomycin | 1 | 2013 | 54 | 0.100 |
Why?
|
| Administration, Topical | 1 | 2013 | 140 | 0.100 |
Why?
|
| Biotin | 1 | 2013 | 43 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2008 | 1017 | 0.100 |
Why?
|
| Viral Proteins | 1 | 1995 | 358 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 128 | 0.100 |
Why?
|
| Rabbits | 1 | 2013 | 673 | 0.100 |
Why?
|
| Axons | 1 | 2015 | 390 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 7104 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 1179 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1011 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 1694 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 1995 | 1422 | 0.080 |
Why?
|
| Eye Neoplasms | 1 | 2010 | 46 | 0.080 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2010 | 43 | 0.080 |
Why?
|
| Vascular Neoplasms | 1 | 2010 | 33 | 0.080 |
Why?
|
| Algorithms | 1 | 2017 | 1722 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2017 | 800 | 0.080 |
Why?
|
| Phenotype | 2 | 2018 | 4528 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2016 | 1068 | 0.080 |
Why?
|
| Disease Progression | 1 | 2015 | 2225 | 0.070 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2010 | 153 | 0.070 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2007 | 15 | 0.070 |
Why?
|
| Carcinoma, Small Cell | 1 | 2007 | 41 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2023 | 17416 | 0.070 |
Why?
|
| Streptococcus pyogenes | 2 | 1998 | 79 | 0.070 |
Why?
|
| Adult | 6 | 2024 | 31575 | 0.060 |
Why?
|
| Karyopherins | 1 | 2006 | 36 | 0.060 |
Why?
|
| Cicatrix | 1 | 2007 | 126 | 0.060 |
Why?
|
| Streptococcal Infections | 2 | 1998 | 248 | 0.060 |
Why?
|
| Metamorphosis, Biological | 1 | 2004 | 7 | 0.060 |
Why?
|
| Mutation | 5 | 2008 | 6228 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 3766 | 0.050 |
Why?
|
| Astronauts | 1 | 2025 | 76 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2004 | 136 | 0.050 |
Why?
|
| Bimatoprost | 1 | 2023 | 2 | 0.050 |
Why?
|
| Cloprostenol | 1 | 2023 | 4 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2003 | 77 | 0.050 |
Why?
|
| Ophthalmic Solutions | 1 | 2023 | 90 | 0.050 |
Why?
|
| Amides | 1 | 2023 | 91 | 0.050 |
Why?
|
| Eye Proteins | 1 | 2003 | 232 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2004 | 357 | 0.050 |
Why?
|
| Molecular Sequence Data | 4 | 2008 | 3770 | 0.050 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2022 | 18 | 0.050 |
Why?
|
| Neuroglia | 1 | 2004 | 212 | 0.050 |
Why?
|
| Syndrome | 1 | 2025 | 1174 | 0.050 |
Why?
|
| Animals, Genetically Modified | 3 | 2008 | 338 | 0.040 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 56 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2004 | 575 | 0.040 |
Why?
|
| United Kingdom | 1 | 2021 | 235 | 0.040 |
Why?
|
| Slit Lamp Microscopy | 1 | 2020 | 6 | 0.040 |
Why?
|
| Glaucoma Drainage Implants | 1 | 2020 | 9 | 0.040 |
Why?
|
| Descemet Stripping Endothelial Keratoplasty | 1 | 2020 | 10 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 613 | 0.040 |
Why?
|
| Base Sequence | 3 | 2008 | 2899 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2006 | 1098 | 0.040 |
Why?
|
| Corneal Diseases | 1 | 2020 | 96 | 0.040 |
Why?
|
| Cataract Extraction | 1 | 2020 | 152 | 0.040 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2020 | 216 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 549 | 0.040 |
Why?
|
| 3T3 Cells | 2 | 1995 | 124 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 6572 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 1131 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 1538 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 1995 | 454 | 0.030 |
Why?
|
| Tertiary Healthcare | 1 | 2017 | 20 | 0.030 |
Why?
|
| Carrier State | 1 | 1997 | 77 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2020 | 707 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2008 | 291 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 601 | 0.030 |
Why?
|
| Genes, Regulator | 1 | 1995 | 47 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 1995 | 11 | 0.030 |
Why?
|
| Cations | 1 | 2015 | 37 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 1995 | 41 | 0.030 |
Why?
|
| Sequence Homology | 1 | 1995 | 63 | 0.030 |
Why?
|
| Heterogeneous Nuclear Ribonucleoprotein A1 | 1 | 1995 | 9 | 0.030 |
Why?
|
| A Kinase Anchor Proteins | 1 | 1995 | 21 | 0.030 |
Why?
|
| Retinal Bipolar Cells | 1 | 2015 | 41 | 0.030 |
Why?
|
| Chloride Channels | 1 | 2015 | 63 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1995 | 112 | 0.030 |
Why?
|
| Mitosis | 1 | 1995 | 196 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1995 | 311 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1995 | 209 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 3416 | 0.030 |
Why?
|
| Neurons | 1 | 2004 | 1998 | 0.030 |
Why?
|
| Collagen | 1 | 1995 | 303 | 0.030 |
Why?
|
| DNA Helicases | 1 | 1995 | 239 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 3092 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2017 | 1229 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 1548 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1952 | 0.020 |
Why?
|
| Synapses | 1 | 2015 | 456 | 0.020 |
Why?
|
| Antigens, CD20 | 1 | 2010 | 40 | 0.020 |
Why?
|
| Retinal Hemorrhage | 1 | 2010 | 24 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 112 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 3011 | 0.020 |
Why?
|
| Paraplegia | 1 | 2010 | 96 | 0.020 |
Why?
|
| Retinal Detachment | 1 | 2010 | 71 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1443 | 0.020 |
Why?
|
| Proteins | 1 | 1995 | 1035 | 0.020 |
Why?
|
| Risk Factors | 2 | 2021 | 10946 | 0.020 |
Why?
|
| Lacrimal Apparatus | 1 | 2010 | 128 | 0.020 |
Why?
|
| DNA Probes | 1 | 2008 | 124 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1995 | 1799 | 0.020 |
Why?
|
| Genes, Insect | 1 | 2008 | 126 | 0.020 |
Why?
|
| Body Patterning | 1 | 2008 | 130 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 1998 | 93 | 0.020 |
Why?
|
| Serotyping | 2 | 1998 | 178 | 0.020 |
Why?
|
| Minnesota | 2 | 1998 | 180 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2008 | 208 | 0.020 |
Why?
|
| Biopsy | 1 | 2010 | 1284 | 0.020 |
Why?
|
| Cilia | 1 | 2006 | 79 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 2669 | 0.010 |
Why?
|
| Rhodopsin | 1 | 2004 | 69 | 0.010 |
Why?
|
| Larva | 1 | 2004 | 260 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2003 | 301 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 1659 | 0.010 |
Why?
|
| United States | 1 | 2017 | 11667 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 1608 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 3831 | 0.010 |
Why?
|
| Fasciitis, Necrotizing | 1 | 1998 | 30 | 0.010 |
Why?
|
| Pharyngitis | 1 | 1997 | 34 | 0.010 |
Why?
|
| Molecular Epidemiology | 1 | 1997 | 146 | 0.010 |
Why?
|
| Virulence | 1 | 1997 | 279 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1997 | 217 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 1997 | 430 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1995 | 33 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1997 | 494 | 0.010 |
Why?
|
| Genes, ras | 1 | 1995 | 100 | 0.010 |
Why?
|
| Disease Outbreaks | 1 | 1997 | 329 | 0.010 |
Why?
|
| Schools | 1 | 1997 | 236 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 584 | 0.010 |
Why?
|
| Rats | 1 | 1995 | 3609 | 0.000 |
Why?
|
| Child | 1 | 1997 | 25786 | 0.000 |
Why?
|